CAPRICOR THERAPEUTICS

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

05 11 2024 09:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

18 10 2024 16:01:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock

17 10 2024 06:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Proposed Public Offering of Common Stock

16 10 2024 16:17:48 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

15 10 2024 12:27:21 提供 NetDania Notify

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society Congress

11 10 2024 09:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

09 10 2024 09:15:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

04 10 2024 09:47:23 提供 NetDania Notify

Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress

04 10 2024 09:15:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

01 10 2024 09:48:05 提供 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

30 9 2024 11:30:56 提供 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

25 9 2024 09:45:14 提供 NetDania Notify

NetDania - New 12 months High: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

24 9 2024 09:45:18 提供 NetDania Notify

Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

24 9 2024 08:00:01 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

23 9 2024 09:25:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Signs Binding Term Sheet with Nippon Shinyaku for European Expansion and Commercialization of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

17 9 2024 09:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences

06 9 2024 08:30:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

07 8 2024 16:05:01 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present Second Quarter 2024 Financial Results and Recent Corporate Update on August 7

31 7 2024 09:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

01 7 2024 09:00:00 提供 Nasdaq GlobeNewswire